• Mira Dreesen, Veerle Foulon, Kris Vanhaecht, Martin Hiele, Lutgart De Pourcq, Loris Pironi, Andre Van Gossum, Geert Wanten, Janet P Baxter, Francisca Joly, Cristina Cuerda, and Ludo Willems.
• Department of Pharmaceutical and Pharmacological Sciences, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Leuven, Belgium. mira.dreesen@uzleuven.be
• Clin Nutr. 2013 Feb 1;32(1):59-64.

Background & AimsHPN patients with benign diseases deserve professional care as they have to deal with complex techniques and risk potentially dangerous complications. The aim was to highlight main outcome quality indicators and to develop a set of key interventions to direct multidisciplinary teams in providing qualitative care.MethodsA two-round Delphi approach was used to build consensus on the most important outcome indicators and on 59 interventions identified in existing guidelines on HPN. Comments and interventions newly identified in the first round were co-evaluated in the second round.Results29 experts from 9 countries completed the two-round Delphi approach. The outcome indicators rated as the most important are 1) incidence of catheter-related infections, 2) incidence of readmission and quality of life (shared second place) and 3) incidence of dehydration. Sixty eight of a total of 89 interventions were considered as important for the quality of care, of which 46 are based on published guidelines and 22 were newly suggested by the Delphi panel.ConclusionsUsing a two-round Delphi approach, consensus was reached for the majority of interventions concerning HPN patients with benign diseases. This set of 68 interventions could be of use as a starting point for quality-improvement programs.Copyright © 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

33 keywords...

hide…